Skip to content

Exercise Changes to Peripheral Blood Mononuclear Cells in Children

PBMC, Exercise and Children: Initial Mechanisms

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00585403
Enrollment
0
Registered
2008-01-03
Start date
2004-12-31
Completion date
2004-12-31
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Development, Growth, Obesity, Physical Fitness

Brief summary

The goal of this research is to determine how the peripheral immune system is altered by exercise and differences related to gender, pubertal status and health.

Detailed description

SPECIFIC AIMS: 1. To systematically measure for the first time in healthy children and adolescents the effects of brief bouts of exercise on: 1. Numbers of circulating PMBCs, their subsets and key intercellular adhesion molecules (ICAMs). 2. PBMC gene regulation of stress, inflammatory, and growth/repair mediators \[including: interleukin-4 (IL-4), IL-6, IL-10, tumor necrosis factor-alpha (TNF-alpha), interferon-gamma), growth hormone (GH), insulin-like growth factor-I (IGF-I), heat shock proteins (Hsp)\]. 3. Circulating (serum) and intracellular PBMC levels of key mediators by flow cytometry and cell culture techniques. 4. Circulating endogenous triggers of PBMC mediator responses-soluble Hsp, IL-6, and F2-isoprostanes. 2. To determine how the acute PBMC responses are altered by gender, pubertal status, body composition (measured by whole-body and regional DEXA), and fitness (measured by progressive cycle ergometry and gas exchange). 3. To determine the relationship in healthy children and adolescents among acute PBMC responses to exercise, biochemical precursors of the metabolic syndrome (insulin, glucose, lipids), and the balance of the TH1/TH2 immune response.

Interventions

None listed

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* appropriate Tanner Stage * No evidence of disease or disability

Exclusion criteria

* no use of antiinflammatory medications, alcohol, illegal drugs or bronchodilators * elite children participating in extensive exercise or dance programs * pregnant

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026